obesity drug news today glp-1 oct 27 2025 Market Weight loss with GLP-1 medicines

Larger randomized controlled trials with long-term follow-up are necessary to confirm these associations and evaluate the risk-benefit ratios

GLP-1 Probiotic PRO by Pendulum is designed to support metabolic health by enhancing GLP-1 production, a hormone involved in blood sugar regulation

Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

Personalized Care To Ensure Effective Weight Loss Results.